CBIO
Price:
$0.5113
Market Cap:
$921.73M
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB 2782-PEG, a component 3 (C3) degrader for the treatment of dry age-related macular degeneration (dAMD); and CB 4332 for patients with deficiencies in complement factor I (CFI), including dAMD. The company also develops ProTUNE C3b/C4b degrader and ImmunoTUNE C3a/C5a degrader platforms designed to target other disorders of the complement or inflammator...[Read more]
Industry
Biotechnology
IPO Date
2006-04-12
Stock Exchange
NASDAQ
Ticker
CBIO
According to Catalyst Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.02. This represents a change of -100.06% compared to the average of 40.25 of the last 4 quarters.
The mean historical PE Ratio of Catalyst Biosciences, Inc. over the last ten years is 4.75. The current -0.02 PE Ratio has changed -152.02% with respect to the historical average. Over the past ten years (40 quarters), CBIO's PE Ratio was at its highest in in the June 2022 quarter at 88.14. The PE Ratio was at its lowest in in the March 2018 quarter at -157.79.
Average
4.75
Median
-20.02
Minimum
-44.16
Maximum
265.01
Discovering the peaks and valleys of Catalyst Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 409.25%
Maximum Annual PE Ratio = 265.01
Minimum Annual Increase = -5671.56%
Minimum Annual PE Ratio = -44.16
Year | PE Ratio | Change |
---|---|---|
2023 | -16.85 | -106.36% |
2022 | 265.01 | -5671.56% |
2021 | -4.76 | -85.45% |
2020 | -32.68 | 40.96% |
2019 | -23.19 | -47.49% |
2018 | -44.16 | 29.01% |
2017 | -34.23 | 409.25% |
2016 | -6.72 | -52.28% |
2015 | -14.09 | -65.52% |
2014 | -40.85 | -8.89% |
The current PE Ratio of Catalyst Biosciences, Inc. (CBIO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
81.13
5-year avg
37.51
10-year avg
4.75
Catalyst Biosciences, Inc.’s PE Ratio is less than HTG Molecular Diagnostics, Inc. (0), greater than Bellerophon Therapeutics, Inc. (-0.05), greater than Akari Therapeutics, Plc (-0.73), greater than Benitec Biopharma Inc. (-6.22), greater than Pulmatrix, Inc. (-2.26),
Company | PE Ratio | Market cap |
---|---|---|
0 | $1.06M | |
-0.05 | $366.98K | |
-0.73 | $14.21M | |
-6.22 | $282.78M | |
-2.26 | $21.80M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Catalyst Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Catalyst Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Catalyst Biosciences, Inc.'s PE Ratio?
How is the PE Ratio calculated for Catalyst Biosciences, Inc. (CBIO)?
What is the highest PE Ratio for Catalyst Biosciences, Inc. (CBIO)?
What is the 3-year average PE Ratio for Catalyst Biosciences, Inc. (CBIO)?
What is the 5-year average PE Ratio for Catalyst Biosciences, Inc. (CBIO)?
How does the current PE Ratio for Catalyst Biosciences, Inc. (CBIO) compare to its historical average?